MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers

3 years ago

EscharEx Showed Safe, Effective and Rapid Debridement in VLUs and DFUsData Demonstrates EscharEx Reduced Wound Size, Biofilm and Bacterial Burden…

Zynerba Pharmaceuticals Announces Panel Presentation and Poster Presentations at the NFXF International Fragile X Conference

3 years ago

DEVON, Pa., July 07, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid…

RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results

3 years ago

-- Expects second quarter 2022 preliminary UPNEEQ net product sales of approximately $8.4 million, representing an increase of 42% from…

Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen

3 years ago

This becomes the 6th Senhance Hospital in GermanyRESEARCH TRIANGLE PARK, N.C., July 07, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc.…

ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022

3 years ago

PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…

Immuron Receives European Patent Notification on Drug Composition to Treat Clostridioides difficile Associated Disease

3 years ago

MELBOURNE, Australia, July 07, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on…

ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences

3 years ago

ACTO CXO Team (left to right): Kapil Kalra (CCO), John Schultz (CSO), Alison Muller (CMO), Parth Khanna (CEO), Kumar Erramilli…

EVEON announces the launch of the European project INDENEO to develop an innovative delivery system for nose to brain administration of biological and advanced therapy drugs to neonates

3 years ago

EVEON, designer and manufacturer of medical devices for the preparation and delivery of drugs, announces the launch of a European…

Calibre Scientific UK Relocates to State-Of-The-Art Facility in the Advanced Manufacturing Park, Sheffield

3 years ago

LOS ANGELES, July 07, 2022 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the relocation of three key UK…

Chr. Hansen Holding A/S Interim Report Q3 2021/22

3 years ago

Company announcement no. 05/2022 July 7, 2022 Solid Q3 in an uncertain macroeconomic environment Statement by CEO Mauricio Graber: “The…